跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Takeda Pharma A/S
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 8, 2021
Approval ID
7d13f1797f7c5010
Company
Takeda Pharma A/S
Type
Standard
Approval Details
Approval Id
7d13f1797f7c5010
Drug Cima Aemps Name
ADCETRIS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
112794001IP
Holder Company Name
Takeda Pharma A/S
Marketing Company Name
Abacus Medicine A/S
Holder Company Detail Path
/organization/takeda-pharma-a-s
Authorization Date
2021-01-08
Dosage Form
POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
50 MG
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Takeda Pharma A/S
Company Detail Path
/organization/takeda-pharma-a-s
Company Information
Pharmaceutical Company Name
Takeda Pharma A/S
Country Name
Denmark
City Name
vallensbæk strand,hovedstaden,country_dk
Address
Delta Park 45
Website
http://www.takeda.dk
Active Ingredients
BRENTUXIMAB VEDOTINA
50 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 8, 2021
Approval ID
7d13f1797f7c5010
Type
Standard
Back to CIMA-AEMPS Approvals